Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Thursday, November 19, 2015 12:33:00 PM
bullish 2.99
## source: finance.yahoo.com
Wed, 18 Nov 2015 18:04:21 GMT ~ FORTRESS BIOTECH, INC. Financials
read full: http://finance.yahoo.com/q/is?s=fbio
*********************************************************
Mon, 09 Nov 2015 13:20:51 GMT ~ FORTRESS BIOTECH, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex
read full: http://biz.yahoo.com/e/151109/fbio8-k.html
*********************************************************
Mon, 09 Nov 2015 12:26:10 GMT ~ Fortress Biotech Reports Financial Results for the Third Quarter 2015 Ended September 30, 2015
[at noodls] - 955dc7ec-06f2-4a7b-84b2-7b088adca1f8.pdf FORTRESS BIOTECH REPORTS FINANCIAL RESULTS FOR THE THIRD QUARTER 2015 ENDED SEPTEMBER 30, 2015 New York, NY - November 9, 2015 - Fortress Biotech, Inc. (NASDAQ: ...
read full: http://www.noodls.com/view/BC87299A5BB016A84985CF7AE4F76B7BCBFBB91C
*********************************************************
Mon, 09 Nov 2015 12:00:00 GMT ~ Fortress Biotech Reports Financial Results for the Third Quarter 2015 Ended September 30, 2015
[GlobeNewswire] - NEW YORK -- Fortress Biotech, Inc. (NASDAQ:FBIO) announces its financial results for the third quarter ended September 30, 2015.
read full: http://finance.yahoo.com/news/fortress-biotech-reports-financial-results-120000839.html
*********************************************************
Tue, 20 Oct 2015 12:31:30 GMT ~ FORTRESS BIOTECH, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
read full: http://biz.yahoo.com/e/151020/fbio8-k.html
*********************************************************
$FBIO charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$FBIO company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/FBIO/company-info
Ticker: $FBIO
OTC Market Place: Not Available
CIK code: 0001429260
Company name: Fortress Biotech, Inc.
Company website: http://www.coronadobiosciences.com
Incorporated In: DE, USA
Business Description: We are a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of inflammatory diseases and cancer.
$FBIO share structure
## source: otcmarkets.com
Market Value: $140,458,471 a/o Nov 18, 2015
Shares Outstanding: 47,133,715 a/o Nov 09, 2015
Float: Not Available
Authorized Shares: 50,000,000 a/o Sep 30, 2011
Par Value: 0.001
$FBIO extra dd links
Company name: Fortress Biotech, Inc.
Company website: http://www.coronadobiosciences.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/FBIO/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/FBIO/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=FBIO+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=FBIO+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=FBIO+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/FBIO/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/FBIO/news - http://finance.yahoo.com/q/h?s=FBIO+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/FBIO/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/FBIO/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/FBIO/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/FBIO/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/FBIO/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/FBIO/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/FBIO/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/FBIO/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=FBIO+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/FBIO
DTCC (dtcc.com): http://search2.dtcc.com/?q=Fortress+Biotech%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Fortress+Biotech%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Fortress+Biotech%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.coronadobiosciences.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.coronadobiosciences.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.coronadobiosciences.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/FBIO/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/FBIO
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/FBIO/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/FBIO/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/FBIO/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001429260&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/FBIO/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/FBIO/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/FBIO/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/FBIO/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=FBIO&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=FBIO
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/FBIO/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=FBIO+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=FBIO+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=FBIO
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=FBIO
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=FBIO+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/FBIO/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=FBIO+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/FBIO.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=FBIO
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/FBIO/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/FBIO/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/FBIO/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/FBIO/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/FBIO
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/FBIO
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/FBIO:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=FBIO
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=FBIO
$FBIO DD Notes ~ http://www.ddnotesmaker.com/FBIO
Recent FBIO News
- Avenue Therapeutics Announces Reverse Stock Split • GlobeNewswire Inc. • 04/24/2024 11:30:41 AM
- Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights • GlobeNewswire Inc. • 03/28/2024 08:05:13 PM
- Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune Diseases • GlobeNewswire Inc. • 03/28/2024 01:00:51 PM
- Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024 • GlobeNewswire Inc. • 03/25/2024 12:30:00 PM
- Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights • GlobeNewswire Inc. • 03/21/2024 08:01:27 PM
- Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights • GlobeNewswire Inc. • 03/18/2024 08:05:14 PM
- Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea • GlobeNewswire Inc. • 03/18/2024 12:30:30 PM
- Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024 • GlobeNewswire Inc. • 03/15/2024 12:30:01 PM
- Avenue Therapeutics Receives Positive Listing Determination from Nasdaq • GlobeNewswire Inc. • 03/15/2024 12:15:01 PM
- Journey Medical Corporation to Participate in the 36th Annual ROTH Conference • GlobeNewswire Inc. • 03/13/2024 12:30:14 PM
- Fortress Biotech to Participate in 36th Annual ROTH Conference • GlobeNewswire Inc. • 03/12/2024 12:30:16 PM
- Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting • GlobeNewswire Inc. • 03/11/2024 12:30:30 PM
- Avenue Therapeutics to Present BAER-101 Preclinical Data at American Society for Experimental Neurotherapeutics (ASENT) 2024 Annual Meeting • GlobeNewswire Inc. • 03/11/2024 12:00:17 PM
- Mustang Bio Announces Publication in Nature Medicine of Data from Phase 1 Trial Evaluating MB-101 IL13Rα2-targeted CAR T-Cells in High-Grade Glioma • GlobeNewswire Inc. • 03/07/2024 12:30:12 PM
- Fortress Biotech and Cyprium Therapeutics Announce $4.1 Million Grant from NINDS to Further Development of AAV-ATP7A Gene Therapy for Menkes Disease • GlobeNewswire Inc. • 03/04/2024 01:30:24 PM
- Avenue Therapeutics Announces Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101 in a Translational Model of Absence Epilepsy • GlobeNewswire Inc. • 02/22/2024 01:30:08 PM
- Mustang Bio to Participate in the B. Riley Securities 4th Annual Oncology Conference • GlobeNewswire Inc. • 01/11/2024 01:30:39 PM
- Avenue Therapeutics to Present at Sidoti January Micro-Cap Investor Conference • GlobeNewswire Inc. • 01/11/2024 01:00:08 PM
- Avenue Therapeutics Enters into Warrant Exercise Transactions for $5.0 Million in Proceeds • GlobeNewswire Inc. • 01/05/2024 02:15:43 PM
- Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea • GlobeNewswire Inc. • 01/05/2024 01:30:12 PM
- Avenue Therapeutics Reaches Final Agreement with the U.S. FDA for the Phase 3 Safety Study for IV Tramadol • GlobeNewswire Inc. • 01/04/2024 01:30:44 PM
- Fortress Biotech Announces Closing of $11 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules • GlobeNewswire Inc. • 01/03/2024 09:01:28 PM
- Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million • GlobeNewswire Inc. • 01/02/2024 09:05:30 PM
- Avenue Therapeutics Announces Completion of Enrollment in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease) • GlobeNewswire Inc. • 01/02/2024 01:30:37 PM
- Fortress Biotech Announces Pricing of $11 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules • GlobeNewswire Inc. • 12/29/2023 01:20:29 PM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM